Modified method of exchange transfusion in sickle cell disease
β Scribed by Carol A. Talacki; Samir K. Ballas
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 423 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
The treatment of various complications of sickle cell disease has included red cell exchange in the past, and the development of automated pheresis equipment has greatly simplified such exchanges. Traditionally, the patient's red cells have been exchanged while their plasma was returned to them. Recently, plasma factors have been thought to play a role in the pathogenesis of vasoocclusive events. Therefore, we performed whole blood exchange, which consisted of replacement of the patient's plasma with albumin and saline in addition to the usual replacement of erythrocytes. A total of 32 whole blood exchanges were performed on 12 patients with a variety of complications of their disease. The procedure was done using standard pheresis equipment and was relatively simple to perform. There were no serious complications and the clinical outcome was good with 10 out of 12 patients experiencing improvement.
π SIMILAR VOLUMES
An improvcd method for intermittent-flow erythrocytapheresis in patients with sickle cell disease is reported. The method. a modification of the standard red cell exchange procedure for the Haemonetics 30s unit, dilutes with physiologic saline the patient's blood as i ! flows from the draw line and
The transfusion histories over a 33-month period of 50 patients with sickle cell disease were reviewed to determine the frequency of alloimmunization to red cell antigens following transfusion in these patients. There were 30 females and 20 males, aged 19--49 years. Eighteen (36%) were immunized of
We conclude that intravenous immunoglobulin followed by platelet transfusion may serve as a valuable adjunct in the urgent treatment of drug-induced immune thrombocytopenia where progressive, life-threatening thrombocytopenia complicates conventional therapeutic interventions.